Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis MS Pill Gilenya Rejected by U.K. Health-Cost Agency
Novartis MS Pill Gilenya Rejected by U.K. Health-Cost Agency
Novartis MS Pill Gilenya Rejected by U.K. Health-Cost Agency
Submitted by
admin
on November 30, 2011 - 7:42pm
Source:
Bloomberg
News Tags:
Novartis
MS
multiple sclerosis
Gilenya
Headline:
Novartis MS Pill Gilenya Rejected by U.K. Health-Cost Agency
Do Not Allow Advertisers to Use My Personal information
